Yokoyama A, Ohmori T, Muramatsu T, Higuchi S, Yokoyama T, Matsushita S, Matsumoto M, Maruyama K, Hayashida M, Ishii H
National Institute on Alcoholism, Kurihama National Hospital, Kanagawa, Japan.
Int J Cancer. 1996 Nov 4;68(3):313-6. doi: 10.1002/(SICI)1097-0215(19961104)68:3<313::AID-IJC8>3.0.CO;2-4.
In this study, 1,000 Japanese male alcoholics were consecutively screened by upper gastrointestinal endoscopy with esophageal iodine staining. Associations among cancer-detection rates, drinking and smoking habits, and aldehyde dehydrogenase-2 (ALDH2) genotypes were evaluated. A total of 53 patients (5.3%) had histologically confirmed cancer. Esophageal cancer was diagnosed in 36, gastric cancer in 17, and oropharyngolaryngeal cancer in 9 patients: 8 of the esophageal-cancer patients were multiple-cancer patients, with additional cancer(s) in the stomach and/or oropharyngolaryngeal region. Multiple logistic regression revealed that use of stronger alcoholic beverages (whisky or shochu) in contrast with lighter beverages (sake or beer) and smoking of 50 pack-years or more increased the risks for esophageal (odds ratio 3.2 and 2.8 respectively), oropharyngolaryngeal (4.8 and 5.1 respectively) and multiple cancer (10.5 and 11.8 respectively). The inactive form of ALDH2, encoded by the gene ALDH21/22 prevalent in Orientals, exposes them to higher blood levels of acetaldehyde, a recognized animal carcinogen, after drinking. This inactive ALDH2 was detected in 19/36 (52.8%) patients with esophageal cancer, in 5/9 (55.6%) patients with oropharyngolaryngeal cancer, and in 7/8 (87.5%) patients with multiple cancer. All of these gene frequencies far exceeded that in a large alcoholic cohort (80/655, 12.2%). The triple combination of the risk factors of the inactive ALDH2, stronger alcoholic beverages and heavy smoking was more commonly associated with multiple-cancer patients than with patients with esophageal cancer alone (62.5% vs. 7.1%). These results show that the 3 risk factors are important for the development of upper-aerodigestive-tract cancer in Japanese alcoholics. For these high-risk drinkers, regimented screening appears to be indicated.
在本研究中,通过上消化道内镜检查及食管碘染色对1000名日本男性酗酒者进行了连续筛查。评估了癌症检出率、饮酒和吸烟习惯以及乙醛脱氢酶-2(ALDH2)基因型之间的关联。共有53例患者(5.3%)经组织学确诊患有癌症。其中食管癌36例,胃癌17例,口咽喉癌9例:8例食管癌患者为多发癌患者,胃部和/或口咽喉区域还有其他癌症。多因素logistic回归分析显示,与低度酒精饮料(清酒或啤酒)相比,饮用烈性酒精饮料(威士忌或烧酒)以及吸烟量达到50包年及以上会增加患食管癌(优势比分别为3.2和2.8)、口咽喉癌(分别为4.8和5.1)和多发癌(分别为10.5和11.8)的风险。由ALDH21/22基因编码的无活性形式的ALDH2在东方人中较为普遍,饮酒后会使他们暴露于更高水平的乙醛中,乙醛是一种公认的动物致癌物。在36例食管癌患者中有19例(52.8%)检测到这种无活性的ALDH2,9例口咽喉癌患者中有5例(55.6%),8例多发癌患者中有7例(87.5%)。所有这些基因频率均远远超过一个大型酗酒队列中的频率(80/655,12.2%)。无活性ALDH2、烈性酒精饮料和大量吸烟这三个危险因素的三联组合在多发癌患者中比仅患食管癌的患者更为常见(62.5%对7.1%)。这些结果表明,这三个危险因素对日本酗酒者上消化道癌症的发生发展很重要。对于这些高危饮酒者,似乎需要进行规范的筛查。